AUGUST 18, 2023. By CATIE Prevention in Focus Direct-acting antivirals (DAAs) cure hepatitis C, but a person can get hepatitis C again if they are exposed to the virus. This is called reinfection. Reinfections are a reality of hepatitis C work. CATIE talked to three people with expertise in hepatitis C reinfection and asked them to shareRead more
Blog
MARCH 19, 2024. By Dr. Sofia Bartlett Highly effective medications that can cure hepatitis C infection, called direct-acting antivirals (DAAs), have been approved for use in Canada for people over the age of 18 since 2014. These medications are well-tolerated, nearly 100% effective, and have treatment durations of just eight or 12 weeks. DAAs have simplified hepatitis CRead more
By Sofia Bartlett PhD, Senior Scientist, STIBBI, Clinical Prevention Services, BC Centre for Disease Control, Provincial Health Services Authority Since COVID-19 was declared a global pandemic in March 2020, there has been an intense focus on locations where the SARS-CoV-2 virus seems to transmit more frequently or cause more deaths, such as long-term care homesRead more
By Sofia Bartlett PhD, Senior Scientist, STIBBI, Clinical Prevention Services, BC Centre for Disease Control, Provincial Health Services Authority Among people who are incarcerated in Canada, there are an estimated 12,000 people living with hepatitis C infection at any one time, which is a rate of infection almost 30 times higher than in the overallRead more
By Terri Buller-Taylor, Research Manager, Hepatitis Education Canada Hepatitis, Clinical Prevention Services, BC Centre for Disease Control Chronic hepatitis C infection is a leading cause of liver-related illness and death. Liver disease and cirrhosis cause more deaths in Canada than HIV. Other Sexually Transmitted and Blood-Borne Infections (STBBIs) can lead to serious health complications and,Read more
By Stephanie Gin, Nurse Educator, Clinical Prevention Services, BC Centre for Disease Control British Columbia (BC) is now the first province or territory in Canada to recommend one-time birth cohort screening for people born from 1945 to 1965. This update is included in recent revisions to the British Columbia Centre for Disease Control (BCCDC) CommunicableRead more
By Dr. Sofia Bartlett, PhD, Stephanie Gin, RN(C), BSc, MPH & Dr. Terri Buller-Taylor, PhD British Columbia is the first province or territory in Canada to recommend one-time birth cohort screening for hepatitis C among people born from 1945 to 1965. This birth cohort has been identified as a key population that needs to beRead more
